KAHIRA PHARMACEUTICALS AND CHEMICAL INDUSTRIES EGX:CPCI:
KAHIRA PHARMACEUTICALS H1 NET PROFIT AFTER TAX EGP 269 MILLION
KAHIRA PHARMACEUTICALS H1 REVENUE EGP 1.25 BILLION
Kahira Pharmaceuticals H1 Net Profit EGP 269 Million
Kahira Pharmaceuticals & Chemical Industries Co. on 6ix
Earlier from Kahira Pharmaceuticals & Chemical Industries
- Kahira Pharmaceuticals And Chemical Industries Q1 Profit EGP 143.7 Mln
- Kahira Pharmaceuticals And Chemical Industries Shareholders Approve FY Dividend
- Kahira Pharmaceuticals & Chemical Industries: Cairo Pharmaceuticals (CPCI.CA) Reports 6 Months Results
Later from Kahira Pharmaceuticals & Chemical Industries
- Kahira Pharmaceuticals And Chemical Industries 9-Month Profit EGP 412.8 Mln
- Cairo Pharmaceuticals (CPCI.CA) - External Auditor's Report
- Cairo Pharmaceuticals (CPCI.CA) - Disclosure Form for the BOD & the Shareholders' Structure
Follow Kahira Pharmaceuticals & Chemical Industries into a list and get an email when it puts out news.
Follow Kahira Pharmaceuticals & Chemical Industries